Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DuoTrav APS vs. XALACOM® in Ocular Surface Health
NCT00912054Phase 3Terminated
- Sponsor
- Alcon Inc.
- Start
- Mar 2010
- Primary completion
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of travoprost + timolol in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Mar 2010; status: terminated.
02
Drugs
travoprost + timolol
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00912054.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00912054.